DOI QR코드

DOI QR Code

Frequency and Pattern of Noninfectious Adverse Transfusion Reactions at a Tertiary Care Hospital in Korea

  • Cho, Jooyoung (Department of Laboratory Medicine, Yonsei University College of Medicine) ;
  • Choi, Seung Jun (Department of Laboratory Medicine, The Armed Forces Capital Hospital) ;
  • Kim, Sinyoung (Department of Laboratory Medicine, Yonsei University College of Medicine) ;
  • Alghamdi, Essam (Department of Laboratory Medicine, Yonsei University College of Medicine) ;
  • Kim, Hyun Ok (Department of Laboratory Medicine, Yonsei University College of Medicine)
  • Received : 2015.05.21
  • Accepted : 2015.10.01
  • Published : 2016.01.01

Abstract

Background: Although transfusion is a paramount life-saving therapy, there are multiple potential significant risks. Therefore, all adverse transfusion reaction (ATR) episodes require close monitoring. Using the computerized reporting system, we assessed the frequency and pattern of non-infectious ATRs. Methods: We analyzed two-year transfusion data from electronic medical records retrospectively. From March 2013 to February 2015, 364,569 units of blood were transfused. Of them, 334,582 (91.8%) records were identified from electronic nursing records. For the confirmation of ATRs by blood bank physicians, patients' electronic medical records were further evaluated. Results: According to the nursing records, the frequency of all possible transfusion-related events was 3.1%. After the blood bank physicians' review, the frequency was found to be 1.2%. The overall frequency of febrile non-hemolytic transfusion reactions (FNHTRs) to red blood cells (RBCs), platelet (PLT) components, and fresh frozen plasmas (FFPs) were 0.9%, 0.3%, and 0.2%, respectively, and allergic reactions represented 0.3% (RBCs), 0.9% (PLTs), and 0.9% (FFPs), respectively. The pre-storage leukocyte reduction significantly decreased the frequency of FNHTRs during the transfusion of RBCs (P<0.01) or PLTs ($P{\fallingdotseq}0.01$). Conclusions: The frequency of FNHTRs, allergic reactions, and "no reactions" were 22.0%, 17.0%, and 60.7%, respectively. Leukocyte-reduction was associated with a lower rate of FNHTRs, but not with that of allergic reactions. The development of an effective electronic reporting system of ATRs is important in quantifying transfusion-related adverse events. This type of reporting system can also accurately identify the underlying problems and risk factors to further the quality of transfusion care for patients.

Keywords

Acknowledgement

Supported by : Ministry of Health and Welfare

References

  1. Sahu S, Hemlata, Verma A. Adverse events related to blood transfusion. Indian J Anaesth 2014;58:543-51. https://doi.org/10.4103/0019-5049.144650
  2. Hendrickson JE and Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg 2009;108:759-69. https://doi.org/10.1213/ane.0b013e3181930a6e
  3. Kato H, Nakayama T, Uruma M, Okuyama Y, Handa M, Tomiyama Y, et al. A retrospective observational study to assess adverse transfusion reactions of patients with and without prior transfusion history. Vox Sang 2015;108:243-50. https://doi.org/10.1111/vox.12208
  4. Tinegate H, Birchall J, Gray A, Haggas R, Massey E, Norfolk D, et al. Guideline on the investigation and management of acute transfusion reactions. Prepared by the BCSH Blood Transfusion Task Force. Br J Haematol 2012;159:143-53. https://doi.org/10.1111/bjh.12017
  5. Fry JL, Arnold DM, Clase CM, Crowther MA, Holbrook AM, Traore AN, et al. Transfusion premedication to prevent acute transfusion reactions: a retrospective observational study to assess current practices. Transfusion 2010;50:1722-30. https://doi.org/10.1111/j.1537-2995.2010.02636.x
  6. Mazzei CA, Popovsky MA, Kopko PM. Noninfectious complications of blood transfusion. In: Mark K, Brenda J, Christophjer D, Connie M, eds. Technical manual. 18th ed. Bethesda, MD: American Association of Blood Banks, 2014:665-96.
  7. Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention Atlanta GA, USA. National Healthcare Safety Network Biovigilance Component Hemovigilance Module Surveillance Protocol c.2.1.3. http://www.cdc.gov/nhsn/PDFs/Biovigilance/BV-HV-protocol-current.pdf (Updated on August 2014).
  8. Yeh SP, Chang CW, Chen JC, Yeh WC, Chen PC, Chuang SJ, et al. A well-designed online transfusion reaction reporting system improves the estimation of transfusion reaction incidence and quality of care in transfusion practice. Am J Clin Pathol 2011;136:842-7. https://doi.org/10.1309/AJCPOQNBKCDXFWU3
  9. de Vries RR, Faber JC, Strengers PF; Board of the International Haemovigilance Network. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang 2011;100:60-7. https://doi.org/10.1111/j.1423-0410.2010.01442.x
  10. Uhlmann EJ, Isgriggs E, Wallhermfechtel M, Goodnough LT. Prestorage universal WBC reduction of RBC units does not affect the incidence of transfusion reactions. Transfusion 2001;41:997-1000. https://doi.org/10.1046/j.1537-2995.2001.41080997.x
  11. Yazer MH, Podlosky L, Clarke G, Nahirniak SM. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Transfusion 2004;44:10-5. https://doi.org/10.1046/j.0041-1132.2003.00518.x
  12. Bilgin YM, van de Watering LM, Brand A. Clinical effects of leucoreduction of blood transfusions. Neth J Med 2011;69:441-50.
  13. Harvey AR, Basavaraju SV, Chung KW, Kuehnert MJ. Transfusion-related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012. Transfusion 2015;55:709-18. https://doi.org/10.1111/trf.12918
  14. Wang RR, Triulzi DJ, Qu L. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Am J Clin Pathol 2012;138:255-9. https://doi.org/10.1309/AJCP5H7EKZTGGBKZ
  15. Paglino JC, Pomper GJ, Fisch GS, Champion MH, Snyder EL. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Transfusion 2004;44:16-24. https://doi.org/10.1046/j.0041-1132.2004.00608.x
  16. Dasararaju R and Marques MB. Adverse effects of transfusion. Cancer Control 2015;22:16-25. https://doi.org/10.1177/107327481502200104

Cited by

  1. Incidence of Adverse Transfusion Reactions from an Institutional Hemovigilance System: A Single Center Study vol.29, pp.1, 2018, https://doi.org/10.17945/kjbt.2018.29.1.51
  2. A Case Report of Transfusion-associated Circulatory Overload vol.9, pp.1, 2016, https://doi.org/10.3343/lmo.2019.9.1.30
  3. Case Series of Transfusion-Related Acute Lung Injury in a Tertiary Hospital and a Practical Comparison with the New Diagnostic Criteria vol.30, pp.3, 2016, https://doi.org/10.17945/kjbt.2019.30.3.219
  4. Associated Factors With Acute Transfusion Reaction From Hospital Online Reporting Events: A Retrospective Cohort Study vol.16, pp.4, 2020, https://doi.org/10.1097/pts.0000000000000527
  5. Frequency and clinical characteristics of adverse transfusion reactions in hospitalized patients: A retrospective review of electronic medical records vol.9, pp.4, 2016, https://doi.org/10.4168/aard.2021.9.4.225
  6. A Retrospective Analysis of Transfusion Reactions at a Tertiary Care Center: An Institutional Hemovigilance Study vol.52, pp.12, 2016, https://doi.org/10.3928/00220124-20211108-10